First Description of Novel End-Organ Effects by Speed Modulation Using the Aortix™ Device
Case Reports in Cardiology · 24.04.2024 · 2024 · 1-6
DOI: 10.1155/2024/7430212 ↗Kurz gefasst
Fallbericht in der Zeitschrift Case Reports in Cardiology, erschienen am 24.04.2024. Verfasst von Ajay Bhandari und 4 weiteren Autor:innen. Beteiligte Einrichtung: University of South Florida, Tampa, FL, USA. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aortix™ is a novel percutaneous mechanical circulatory support device designed to facilitate diuresis in patients with cardiorenal syndrome. We describe for the first time the development of end-organ hypoperfusion from excess blood acceleration at the nominal setting and demonstrate through temporal-perfusion marker curves, the potential for speed modulation to optimize results. This will inform future device development and investigation of patient-specific device titration.
Autor:innen und Institutionen
- University of South Florida, Tampa, FL, USA.
ORCID-Profile: Ajay Bhandari
Zitieren
APA
Bhandari, A., Dunham, A., Bassily, E., Mohanty, B. D., & Wu, R. (2024). First Description of Novel End-Organ Effects by Speed Modulation Using the Aortix™ Device. Case Reports in Cardiology, 2024, 1-6. https://doi.org/10.1155/2024/7430212
Vancouver
Bhandari A, Dunham A, Bassily E, Mohanty BD, Wu R. First Description of Novel End-Organ Effects by Speed Modulation Using the Aortix™ Device. Case Reports in Cardiology. 2024;2024:1-6. doi:10.1155/2024/7430212
BibTeX
@article{Bhandari2024,
author = {Bhandari, Ajay and Dunham, Alden and Bassily, Emmanuel and Mohanty, Bibhu D and Wu, Robby},
title = {First Description of Novel End-Organ Effects by Speed Modulation Using the Aortix™ Device},
journal = {Case Reports in Cardiology},
year = {2024},
volume = {2024},
pages = {1--6},
doi = {10.1155/2024/7430212}
}
EUVIMED